Related references
Note: Only part of the references are listed.A Novel PAK1-Notch1 Axis Regulates Crypt Homeostasis in Intestinal Inflammation
Adrian Frick et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)
Knockdown of PAK1 Inhibits the Proliferation and Invasion of Non-Small Cell Lung Cancer Cells Through the ERK Pathway
Si Wang et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2020)
Systemic analysis of the expression and prognostic significance of PAKs in breast cancer
Yifang Dang et al.
GENOMICS (2020)
PAK1 expression determines poor prognosis and immune evasion in metastatic renal cell carcinoma patients
Yang Qu et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)
Identification of a novel PAK1 inhibitor to treat pancreatic cancer
Jiaqi Wang et al.
ACTA PHARMACEUTICA SINICA B (2020)
Clinicopathological significance and angiogenic role of the constitutive phosphorylation of the FOXO1 transcription factor in colorectal cancer
Young San Ko et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
PAK1 as a Potential Therapeutic Target in Male Smokers with EGFR-Mutant Non-Small Cell Lung Cancer
Jae Heun Chung et al.
MOLECULES (2020)
Emerging Targeted Therapies for the Treatment of Non-small Cell Lung Cancer
Patrick R. Halliday et al.
CURRENT ONCOLOGY REPORTS (2019)
Clinicopathological significance and prognostic role of tumor-infiltrating lymphocytes in colorectal cancer
Young San Ko et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2019)
Protein Kinase C-ζ stimulates colorectal cancer cell carcinogenesis via PKC-ζ/Rac1/Pak1/β-Catenin signaling cascade
S. M. Anisul Islam et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)
p21 Activated kinase 1: Nuclear activity and its role during DNA damage repair
Eloy Andres Perez-Yepez et al.
DNA REPAIR (2018)
BRG1 is correlated with poor prognosis in colorectal cancer
Jung-Soo Pyo et al.
HUMAN PATHOLOGY (2018)
Upregulation of P21-Activated Kinase 1 (PAK1)/CREB Axis in Squamous Non-Small Cell Lung Carcinoma
Jae Heun Chung et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Overexpression of PAK1 Correlates with Aberrant Expression of EMT Markers and Poor Prognosis in Non-Small Cell Lung Cancer
Zhiying Yang et al.
JOURNAL OF CANCER (2017)
PAK1 Is a Novel Therapeutic Target in Tyrosine Kinase Inhibitor-Resistant Lung Adenocarcinoma Activated by the PI3K/AKT Signaling Regardless of EGFR Mutation
De-Wei Wu et al.
CLINICAL CANCER RESEARCH (2016)
PAK1 modulates a PPARγ/NF-κB cascade in intestinal inflammation
Kyle Dammann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome
Ashley Pandolfi et al.
BLOOD (2015)
Overexpression of PAK1 Promotes Cell Survival in Inflammatory Bowel Diseases and Colitis-associated Cancer
Vineeta Khare et al.
INFLAMMATORY BOWEL DISEASES (2015)
Mesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1
Vineeta Khare et al.
BIOCHEMICAL PHARMACOLOGY (2013)
P21-activated kinase 1 promotes colorectal cancer survival by up-regulation of hypoxia-inducible factor-1α
Kevin H. Liu et al.
CANCER LETTERS (2013)
P-21 activated kinase 1 knockdown inhibits β-catenin signalling and blocks colorectal cancer growth
Hong He et al.
CANCER LETTERS (2012)
PAK1 Kinase Promotes Cell Motility and Invasiveness through CRK-II Serine Phosphorylation in Non-Small Cell Lung Cancer Cells
Matthew Rettig et al.
PLOS ONE (2012)
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
Christy C. Ong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
P21-activated kinase 1 stimulates colon cancer cell growth and migration/invasion via ERK- and AKT-dependent pathways
Nhi Huynh et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Amplification of 11q13 in ovarian carcinoma
Lindsay A. Brown et al.
GENES CHROMOSOMES & CANCER (2008)
Phosphorylated Pak1 level in the cytoplasm correlates with shorter survival time in patients with glioblastoma
Hiroshi Aoki et al.
CLINICAL CANCER RESEARCH (2007)
Modulation of p21-activated kinase 1 alters the behavior of renal cell carcinoma
Gerald C. O'Sullivan et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer
J. Bostner et al.
ONCOGENE (2007)
The kinase-inhibitory domain of p21-activated kinase 1 (PAK1) inhibits cell cycle progression independent of PAK1 kinase activity
M. Thullberg et al.
ONCOGENE (2007)
P21-activated kinase 1: A new molecular marker for intravesical recurrence after transurethral resection of bladder cancer
Masaaki Ito et al.
JOURNAL OF UROLOGY (2007)
Pak-1 expression increases with progression of colorectal carcinomas to metastasis
JH Carter et al.
CLINICAL CANCER RESEARCH (2004)
Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma
P Schraml et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
p21-activated kinases: three more join the Pak
ZM Jaffer et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2002)
Share Paper
